" /> Human papilloma virus 18 45 E6 E7 mRNA:PrThr:Pt:Cvx:Ord:Probe.amp.tar - CISMeF





Preferred Label : Human papilloma virus 18 45 E6 E7 mRNA:PrThr:Pt:Cvx:Ord:Probe.amp.tar;

LOINC status : ACTIVE;

LOINC display name : HPV 18 45 E6 E7 mRNA NAA probe Ql (Cvx);

LOINC long common name : Human papilloma virus 18 45 E6 E7 mRNA [Presence] in Cervix by NAA with probe detection;

LOINC short name : HPV18 45 E6 E7 mRNA Cvx Ql NAA probe;

LOINC description : Detects E6/E7 viral messenger RNA (mRNA) of human papillomavirus (HPV) types 18 and 45 in cervical specimens from women with positive HPV assay results. E6/E7 oncogenes must be expressed for malignant transformation. For women 21-years and older with atypical squamous cells of undetermined significance (ASC-US) cervical cytology results, and HPV positive assay results, this assay can be used to assess the presence or absence of high-risk HPV genotypes 18, and/or 45. For women 30-years and older, the HPV 18, and/or 45 genotype assay can be used to test samples from women with HPV assay positive results, along with cervical cytology results. This assay has not been evaluated for HPV vaccinated patients or in cases of suspected abuse. It does not differentiate HPV 18 and HPV 45. This term was created for, but not limited in use to, the Aptima HPV 16 18/45 genotype assay which uses target capture, target amplification by transcription-mediated amplification and detection of the amplification products by hybridization protection. To report results for HPV 16 see Human papilloma virus 16 E6 E7 mRNA [Presence] in Cervix by Probe and signal amplification method [LOINC: 82456-5].;

Details


Keyword's position in hierarchy(ies) : arborescence

You can consult :


Nous contacter.
27/04/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.